ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: SA-PO856

CD11c-Specific Ablation of SHP-1 Results in Renal Fibrosis with Age

Session Information

Category: CKD (Non-Dialysis)

  • 1903 CKD (Non-Dialysis): Mechanisms

Authors

  • Watanabe, Mitsuharu, Gunma University Graduate School of Medicine, Maebashi, Japan
  • Kaneko, Yoriaki, Gunma University Graduate School of Medicine, Maebashi, Japan
  • Kinoshita, Masato, Gunma University Graduate School of Medicine, Maebashi, Japan
  • Ohishi, Yuko, Gunma University Graduate School of Medicine, Maebashi, Japan
  • Sakairi, Toru, Gunma University Graduate School of Medicine, Maebashi, Japan
  • Ikeuchi, Hidekazu, Gunma University Graduate School of Medicine, Maebashi, Japan
  • Nojima, Yoshihisa, Japan Red Cross Maebashi Hospital, Maebashi, Japan
  • Hiromura, Keiju, Gunma University Graduate School of Medicine, Maebashi, Japan
Background

Renal mononuclear phagocytes (rMoPh) which express traditional macrophage and dendritic cell marker, F4/80 and CD11c respectively, have attracted attention because of their immunoregulatory roles in healthy and diseased kidneys (JASN 23:194, 2012). We have previously generated CD11c-specific SHP-1 conditional knockout mice (SHP-1 CKO) which lack a protein tyrosine phosphatase, SHP-1, and reported that they spontaneously develop tubulointerstitial nephritis characterized by the marked accumulation of CD11c+F4/80+ double-positive rMoPh, (J Immunol 2012, ASN 2016). In the present study, we further analyzed the kidney of SHP-1 CKO to clarify the precise contribution of rMoPh to the development of the nephritis.

Methods

The kidneys obtained from SHP-1 CKO and its control mice (Ctrl) at the age of 40 weeks and were analyzed; in particular, the expressions of vimentin, a marker of mesenchymal cells, and α-smooth muscle actin (α-SMA), a marker of myofibroblasts, were evaluated by immunohistochemistry. Collagen-digested renal mononuclear cells from SHP-1 CKO and Ctrl were analyzed by flow cytometry (FCM).

Results

Masson’s trichrome and Sirius Red staining showed that the area of renal fibrosis was significantly increased in SHP-1 CKO compared to Ctrl. The immunohistochemical analysis revealed marked expression of vimentin and moderate expression of α-SMA in tubulointerstitial area of SHP-1 CKO. Intracellular FCM staining revealed majority of vimentin as well as α-SMA positive-cells were CD11c+F4/80+ double-positive rMoPh in SHP-1 CKO. A small number of CD45-, non-hematopoietic cells, were positive for vimentin or α-SMA, but not significantly different compared to Ctrl. To confirm the efficacy of depletion of SHP-1, we examined the SHP-1 expression in rMoPh by intracellular FCM staining. About 70% of CD11c+F4/80+ rMoPh did not express SHP-1. These results suggested that SHP-1 depletion in CD11c+F4/80+ rMoPh led to the upregulation of vimentin and α-SMA, and directly caused renal fibrosis.

Conclusion

Depletion of SHP-1 in CD11c+F4/80+ rMoPh induces renal tubulointerstitial nephritis and fibrosis with age. In addition, transformation of CD11c+F4/80+ rMoPh into myofibroblasts could be involved in underlying mechanisms of renal fibrosis.